Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
Investor Relations Exec Charged With Insider Trading Opts For Business Extremely Casual At Court AppearanceBy Bess Levin
Michael Dupre Lucarelli, a former executive at Manhattan investor relations firm Lippert/Heilshorn, was charged with making almost $1 million in fraudulent profits by trading on his early access to companies’ press releases. The alleged insider trading happened before small, publicly traded companies announced earnings, mergers or trial-drug results, according to a complaint filed by the Securities and Exchange Commission. FBI agents approached Lucarelli’s boss, Keith Lippert, on July 22, asking him to monitor the alleged scammer, and asked that they keep him employed until their investigation was over, Lippert said. “They had done their homework,” Lippert told The Post…Lucarelli is no stranger to controversy, having once worked for the boiler-room operation H.J. Meyers, and he was forbidden by a regulator from having any contact with registered brokers, according to records.